Here are relevant reports on : oncology-diagnostics-market
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecast to 2027
The global digital pharmacy market growth is primed to transition from USD 96.5 billion in 2022 to USD 211.9 billion by 2027, showcasing a strong CAGR of 17.0%. Key drivers include the rising consumer preference for online medicine purchases, especially during and after the COVID-19 pandemic, market consolidations, and the aging population.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023
The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region - Global Forecast to 2030
The global humanized mouse and rat model market, valued at US$255.8M in 2024, is forecasted to grow at a 8.2% CAGR, reaching US$276.2M by 2025 and US$409.8M by 2030. The surge in the use of humanized models in drug discovery research, rising demand for personalized medicine, and increasing R&D activities in the pharmaceutical & biotechnology industry are contributing to market growth.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Global Forecast to 2028
The global chemiluminescence immunoassay market growth is primed to transition from $13.2 billion in 2023 to $19.0 billion by 2028, showcasing a strong CAGR of 7.5%.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User & Region - Global Forecast to 2028
The global radiation dose management market, valued at US$293 million in 2022, stood at US$343 million in 2023 and is projected to advance at a resilient CAGR of 13.8% from 2023 to 2028, culminating in a forecasted valuation of US$654 million by the end of the period. The growth of this market can be attributed to the increasing use of medical imaging modalities due to rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in installation base of radiology equipment, and growing awareness about radiation dose management
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Urology Surgical Instruments Market by Product (Endoscopes, Endovision Systems, Peripheral Instruments, Consumables and Accessories), Application (Chronic Kidney Diseases, Benign Prostatic Hyperplasia, Oncology) - Global Forecast to 2021
The global urology surgical instruments market size is projected to grow at a CAGR of 8.2%. The growth of this market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population.
- Published: September 2016
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
